Amyloid ␤-protein precursor (A␤PP) is cleaved by ␤-and ␥-secretases to liberate amyloid beta (A␤), the predominant protein found in the senile plaques associated with Alzheimer's disease (AD) and Down syndrome (Masters et al., 1985). Intense investigation by the scientific community has centered on understanding the molecular pathways that underlie the production and accumulation of A␤ Therapeutics that reduce the levels of this tenacious, plaque-promoting peptide may reduce the ongoing neural dysfunction and neuronal degeneration that occurs so profoundly in AD. A␤PP and A␤ production are highly complex and involve still to be elucidated combinations of transcriptional, post-transcriptional, translational and post-translational events that mediate the production, processing and clearance of these proteins. Research in our laboratory for the past two decades has focused on the role of RNA binding proteins (RBPs) in mediating the post-transcriptional as well as translational regulation of APP messenger RNA (mRNA). This review article summarizes our findings, as well as those from other laboratories, describing the identification of regulatory RBPs, where and under what conditions they interact with APP mRNA and how those interactions control A␤PP and A␤ synthesis.
Introduction
The APP gene is located on human chromosome 21 and codes for A␤PP, a ubiquitously expressed, transmembrane protein that localizes to post-synaptic densities, axons, dendrites and neuromuscular junctions (NMJ) (Akaaboune et al., 2000; Shigematsu et al., 1992) , consistent with its multiple roles in cell adhesion (Soba et al., 2005) , synapse formation (Torroja et al., 1999; Yang et al., 2005) and synapse maturation (Akaaboune et al., 2000) . Differential processing of A␤PP by non-amyloidogenic (␣-and ␥-) or amyloidogenic (␤-and ␥-) secretases produces soluble A␤PP (sA␤PP␣ and sA␤PP␤), truncated or full-length amyloid-beta (A␤) and variable length carboxy-terminal fragments (CTFs). The overproduction and ultimate aggregation of A␤ is associated with AD and Down syndrome pathology with current evidence suggesting a more pathogenic role for soluble, pre-aggregated A␤. Despite decades of investigation, much remains to be learned about the normal physiological function of A␤ and other A␤PP catabolites as well as the cellular and molecular pathways that regulate their generation. Clearly, a better understanding of A␤PP biology and gene expression will provide new avenues for therapeutic inter-vention in a number of highly prevalent and currently untreatable neurological disorders.
Our laboratory has studied the mechanisms that underlie the stability and translation of APP mRNA. These studies were triggered by the realization that the 3 untranslated regions (3 UTR) of mouse, rat, human and other species of APP mRNA contained islands of substantial homology, consistent with the presence of cis-acting elements. We hypothesized that APP mRNA was subject to activation-dependent changes in stability and/or translation. Such events could account for both increased mRNA under steady state levels as well as increased translation. Indeed, we and other groups have successfully defined multiple cis-regulatory elements within the 5 -UTR, coding region (CR) and 3 -UTR of APP mRNA that mediate the post-transcriptional stability and/or translation of APP mRNA (Zaidi and Malter, 1994; Amara et al., 1999; Rogers et al., 2002; Westmark et al., 2006; Westmark and Malter, 2007) as well as identified a number of RBPs that bind to these ciselements (Zaidi et al., 1994; Zaidi and Malter, 1995; Westmark and Malter, 2007; Broytman et al., 2008; Lee et al., 2010; Cho et al., 2010) . These mRNA/RBP complexes control the degradation, stability and/or translation of APP mRNA, which directly determines how much A␤PP is synthesized and thus available for processing toward or away from amyloidogenic endpoints.
This review article summarizes our findings, as well as those from the Rogers, Amara and Gorospe laboratories, describing the mRNA/RBP complexes and signaling pathways that regulate A␤PP expression. A detailed understanding of the molecular interactions
